Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients (2020)
- Authors:
- USP affiliated authors: LANCHOTE, VERA LUCIA - FCFRP ; XIMENEZ, JOÃO PAULO BIANCHI - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.1111/bcpt.13368
- Subjects: NEOPLASIAS MAMÁRIAS; QUIMIOTERAPIA; RECEPTORES DE DROGA; ESTRÓGENOS
- Keywords: Cancer chemotherapy; Endoxifen; Generic formulation; Genetic component of pharmacokinetic variability; Tamoxifen
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: West Sussex
- Date published: 2020
- Source:
- Título: Basic Clinical Pharmacology & Toxicology
- ISSN: 1742-7835
- Volume/Número/Paginação/Ano: v. 126, n. 5, p. 432-436, 2020
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
XIMENEZ, João Paulo Bianchi et al. Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients. Basic Clinical Pharmacology & Toxicology, v. 126, n. 5, p. 432-436, 2020Tradução . . Disponível em: https://doi.org/10.1111/bcpt.13368. Acesso em: 10 fev. 2026. -
APA
Ximenez, J. P. B., Lanchote, V. L., Bello, M. A., Iocken, F. H. S., Obadia, R. C. M., Sousa, V. P. de, & Suarez-Kurtz, G. (2020). Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients. Basic Clinical Pharmacology & Toxicology, 126( 5), 432-436. doi:10.1111/bcpt.13368 -
NLM
Ximenez JPB, Lanchote VL, Bello MA, Iocken FHS, Obadia RCM, Sousa VP de, Suarez-Kurtz G. Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients [Internet]. Basic Clinical Pharmacology & Toxicology. 2020 ; 126( 5): 432-436.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1111/bcpt.13368 -
Vancouver
Ximenez JPB, Lanchote VL, Bello MA, Iocken FHS, Obadia RCM, Sousa VP de, Suarez-Kurtz G. Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients [Internet]. Basic Clinical Pharmacology & Toxicology. 2020 ; 126( 5): 432-436.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1111/bcpt.13368 - Farmacocinética não compartimental e populacional do tamoxifeno em pacientes em tratamento para o câncer de mama: estudo do metabolismo, estado hormonal e polimorfismo genético
- Dexamethasone for treating SARS-CoV-2 infection: a systematic review and meta-analysis
- Limited sampling modeling for estimation of phenotypic metrics for CYP enzymes and the ABCB1 transporter using a cocktail approach
- Pharmacogenetic predictors of variability in efavirenz pharmacokinetics in an admixed Brazilian HIV cohort
- Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients
- Determination of mitragynine in rat plasma by LC-MS/MS: application pharmacokinetics
- Enantioselective analysis of cyclophosphamide in human plasma for pharmacokinetic studies
- Impact of stereoselectivity on the kinetic disposition and metabolism of drugs
- Determination of mitragynine in rat plasma by LC-MS/MS: application to pharmacokinetics
- Influence of ethylbenzene inhalation on the enantioselective pharmacokinetics of metoprolol in rats
Informações sobre o DOI: 10.1111/bcpt.13368 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003018750.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
